Association of University Cardiologists
Home
Constitution and
Bylaws
Upcoming
Meetings
Officers
Membership
Roster
Deceased
Members
Membership Nomination
Abstract Forms
How to Contact Us
David Blankenhorn, M.D.
1925 - 1993
Some years ago, human atherosclerosis was believed to be irreversible. Armed with a vision of the future and support from the National Heart, Lung, and Blood Institute (NHLBI), David H. Blankenhorn, MD, embarked on a scientific journey that would span some 40 years and leave in its path a lifetime of accomplishments. This journey would forge new friendships and enduring collaborations, integrate divergent scientific fields, and generate new technology and its applications. It would forever change our perspective on the reversibility of human atherosclerosis and how we could successfully effect its regression.
Dr. Blankenhorn received his medical degree from the University of Cincinnati (Ohio) in 1947. He was a research associate from 1952 to 1954 at the Rockefeller Institute for Medical Research and studied fat and cholesterol metabolism with Dr Edward H. Ahrens, Jr. He joined the faculty of the University of Southern California, Los Angeles, in
1957 and served as the chief of cardiology from 1963 to 1980. In 1980, he became program director of atherosclerosis research and, in 1987, director of the Atherosclerosis Research Institute.
His enthusiasm and dedication to medicine and science are personified by those whom he has trained as well as by his participation in professional societies. His contributions to research are highly regarded and recognized by his peers. He was the recipient of many prestigious awards including a Commonwealth Fellowship, an honorary doctorate from the University of Uppsala (Sweden), the Daniel Drake Medal for achievement in medicine and science from his alma mater, University of Cincinnati College of Medicine.